| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-052614 |
| cik | 2012318 |
| name | INFLECTION POINT ACQUISITION CORP. III |
| sic | 6770 |
| countryba | US |
| stprba | NY |
| cityba | NEW YORK |
| zipba | 10016 |
| bas1 | 167 MADISON AVE |
| bas2 | SUITE 205 #1017 |
| baph | 2124766908 |
| countryma | US |
| stprma | NY |
| cityma | NEW YORK |
| zipma | 10016 |
| mas1 | 167 MADISON AVE |
| mas2 | SUITE 205 #1017 |
| countryinc | |
| stprinc | |
| ein | 981773732 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250609 |
| accepted | 2025-06-09 16:06:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0244896-10q_inflection3_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-052614 | 20250331 | Accrued Offering Costs Current | 386689.0000 | USD | 0 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Additional Paid In Capital | 24156.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-052614 | 20241231 | Common Stock Shares Issued | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | |||
| 0001213900-25-052614 | 20241231 | Common Stock Shares Issued | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | Includes up to 1,100,000 of the founder shares that were subject to surrender by the Sponsor for no consideration depending on the extent to which the underwriters over-allotment is exercised (Note 5). On April 28, 2025, the Company consummated the Initial Public Offering of 25,300,000 units at $10.00 per unit, which includes the full exercise of the underwriters over-allotment option, therefore the 1,100,000 founder shares are no longer subject to forfeiture. | On October 10, 2024, in connection with a r | |
| 0001213900-25-052614 | 20241231 | Deferred Legal Fees | 14456.0000 | USD | 0 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Deferred Offering Costs Included In Accrued Offering Costs | 182081.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20240331 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 9000.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20240331 | General And Administrative Expense | 5975.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Liabilities And Stockholders Equity | 326027.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-052614 | 20250331 | Net Income Loss | -80334.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-052614 | 20250331 | Operating Costs Paid Via Promissory Note Related Party | 5000.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20241231 | Prepaid Expense Current | 5532.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Retained Earnings Accumulated Deficit | -85796.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Retained Earnings Accumulated Deficit | -166130.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20240131 | Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20240131 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-052614 | 20240331 | Stock Issued During Period Shares New Issues | 8433333.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | Includes up to 1,100,000 of the founder shares that were subject to surrender by the Sponsor for no consideration depending on the extent to which the underwriters over-allotment is exercised (Note 5). On April 28, 2025, the Company consummated the Initial Public Offering of 25,300,000 units at $10.00 per unit, which includes the full exercise of the underwriters over-allotment option, therefore the 1,100,000 founder shares are no longer subject to forfeiture. | On October 10, 2024, in connection with a r | |
| 0001213900-25-052614 | 20240331 | Stock Issued During Period Value New Issues | 844.0000 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20250331 | Assets Current | 8638.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20240131 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-052614 | 20240331 | Deferred Offering Costs Included In Accrued Offering Costs | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20250331 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20250331 | Deferred Offering Costs Paid Through Promissory Note Related Party | 5866.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Increase Decrease In Accrued Liabilities | 72596.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -2738.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Liabilities | 386823.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Net Cash Provided By Used In Operating Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-052614 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20250331 | Notes Payable Current | 143594.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240131 | Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20240131 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-052614 | 20240331 | Stockholders Equity | 844.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20241231 | Stockholders Equity | 844.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20241231 | Stockholders Equity | -85796.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-052614 | 20240131 | Stock Issued During Period Shares New Issues | 5750000.0000 | shares | 0 | us-gaap/2025 | Related Party Transaction= Founder Share; Related Party Transactions By Related Party= Sponsor; | ||
| 0001213900-25-052614 | 20240331 | Stock Issued During Period Value New Issues | 24156.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-052614 | 20241231 | Additional Paid In Capital | 24156.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Accrued Liabilities Current | 40875.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Assets Current | 5532.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-052614 | 20250331 | Common Stock Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | |||
| 0001213900-25-052614 | 20250331 | Common Stock Shares Outstanding | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20241231 | Common Stock Value | 844.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Common Stock Value | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | |||
| 0001213900-25-052614 | 20241231 | Deferred Costs | 320495.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Earnings Per Share Diluted | -0.0100 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20240331 | Formation Costs Paid Via Advance From Related Party | 187.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Stockholders Equity | 24156.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-052614 | 20241130 | Stock Issued During Period Shares New Issues | 8433333.0000 | shares | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Sponsor; | ||
| 0001213900-25-052614 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-052614 | 20250331 | Notes Payable Current | 143594.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-052614 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Deferred Legal Fees | 32676.0000 | USD | 0 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Deferred Offering Costs Included In Deferred Legal Fees | 18220.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Earnings Per Share Basic | -0.0100 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20240331 | Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 5788.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20250331 | Liabilities And Stockholders Equity | 535300.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20240331 | Net Income Loss | -5975.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20240331 | Operating Costs Paid Via Promissory Note Related Party | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20250331 | Operating Income Loss | -80334.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240131 | Stockholders Equity | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20250331 | Stockholders Equity | -166130.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-052614 | 20250331 | Accrued Liabilities Current | 113471.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-052614 | 20250331 | Common Stock Shares Issued | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20241231 | Common Stock Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | |||
| 0001213900-25-052614 | 20241231 | Common Stock Value | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | |||
| 0001213900-25-052614 | 20240331 | Deferred Offering Costs Paid Through Promissory Note Related Party | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20240331 | Increase Decrease In Accrued Liabilities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Net Income Loss | -5975.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-052614 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20250331 | Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20240331 | Shares Outstanding | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20241231 | Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20250331 | Stockholders Equity | -141130.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 7333333.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; | Excludes up to 1,100,000 of the founder shares that were subject to surrender by the Sponsor for no consideration depending on the extent to which the underwriters over-allotment is exercised (Note 5). On April 28, 2025, the Company consummated the Initial Public Offering of 25,300,000 units at $10.00 per unit, which includes the full exercise of the underwriters over-allotment option, therefore the 1,100,000 founder shares are no longer subject to forfeiture. | On October 10, 2024, in connection with a r | |
| 0001213900-25-052614 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Deferred Costs | 526662.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Liabilities | 676430.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Notes Payable Current | 126884.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-052614 | 20240331 | Operating Income Loss | -5975.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20241231 | Shares Outstanding | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20250331 | Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20240131 | Stockholders Equity | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20241231 | Stockholders Equity | -60796.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20250331 | Stockholders Equity | 24156.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-052614 | 20240331 | Stock Issued During Period Value New Issues | 25000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Accrued Offering Costs Current | 204608.0000 | USD | 0 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20240331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Formation Costs Paid Via Advance From Related Party | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20250331 | General And Administrative Expense | 80334.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Liabilities Current | 372367.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Liabilities Current | 643754.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20240331 | Net Cash Provided By Used In Operating Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Prepaid Expense Current | 8638.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20240331 | Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 10212.0000 | USD | 1 | 0001213900-25-052614 | |||
| 0001213900-25-052614 | 20240331 | Stockholders Equity | -5975.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-052614 | 20250331 | Stockholders Equity | 844.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 7333333.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20241231 | Assets | 326027.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Assets | 535300.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Common Stock Shares Issued | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | |||
| 0001213900-25-052614 | 20241231 | Common Stock Shares Outstanding | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20250331 | Common Stock Value | 844.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001213900-25-052614 | 20240331 | Deferred Offering Costs Included In Deferred Legal Fees | USD | 1 | 0001213900-25-052614 | ||||
| 0001213900-25-052614 | 20250331 | Net Income Loss | -80334.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Notes Payable Current | 126884.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20250331 | Shares Outstanding | 8433333.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001213900-25-052614 | 20240131 | Stockholders Equity | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-052614 | 20240331 | Stockholders Equity | 19025.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-052614 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | |||
| 0001213900-25-052614 | 20241231 | Stockholders Equity | 24156.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-052614 | 20240930 | Stock Issued During Period Shares New Issues | 7666667.0000 | shares | 0 | us-gaap/2025 | Related Party Transaction= Founder Share; Related Party Transactions By Related Party= Sponsor; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class BOrdinary Shares | The amount of deferred offering costs paid by Sponsor in exchange for issuance of class B ordinary shares. |
| Deferred Offering Costs Paid Through Promissory Note Related Party | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Deferred Offering Costs Paid Through Promissory Note Related Party | The amount of deferred offering costs paid through promissory note - related party. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Formation Costs Paid By Sponsor In Exchange For Issuance Of Class BOrdinary Shares | The amount of formation costs paid by sponsor in exchange for issuance of class B ordinary shares. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class BOrdinary Shares | The amount of prepaid expenses paid by Sponsor in exchange for issuance of class B ordinary shares. |
| Deferred Offering Costs Included In Deferred Legal Fees | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Deferred Offering Costs Included In Deferred Legal Fees | The amount of deferred offering costs included in deferred legal fees. |
| Operating Costs Paid Via Promissory Note Related Party | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Operating Costs Paid Via Promissory Note Related Party | The amount of operating costs paid via promissory note related party. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Formation Costs Paid Via Advance From Related Party | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Formation Costs Paid Via Advance From Related Party | The amount of formation costs paid via advance from related party. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Deferred Offering Costs Included In Accrued Offering Costs | 0001213900-25-052614 | 1 | 0 | monetary | D | D | Deferred Offering Costs Included In Accrued Offering Costs | The amount of deferred offering costs included in accrued offering costs. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Deferred Legal Fees | 0001213900-25-052614 | 1 | 0 | monetary | I | C | Deferred Legal Fees | The amount of deferred legal fees. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Deferred Costs | us-gaap/2025 | 0 | 0 | monetary | I | D | Deferred Costs, Noncurrent | Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Prepaid Expense Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Accrued Offering Costs Current | 0001213900-25-052614 | 1 | 0 | monetary | I | C | Accrued Offering Costs Current | Represent the amount of accrued offering costs current. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-052614 | 2 | 14 | BS | 0 | H | Assets | us-gaap/2025 | TOTAL ASSETS | 0 |
| 0001213900-25-052614 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-052614 | 2 | 11 | BS | 0 | H | Prepaid Expense Current | us-gaap/2025 | Prepaid Expense | 0 |
| 0001213900-25-052614 | 2 | 12 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-052614 | 2 | 13 | BS | 0 | H | Deferred Costs | us-gaap/2025 | Deferred offering costs | 0 |
| 0001213900-25-052614 | 2 | 17 | BS | 0 | H | Accrued Offering Costs Current | 0001213900-25-052614 | Accrued offering costs | 0 |
| 0001213900-25-052614 | 2 | 18 | BS | 0 | H | Notes Payable Current | us-gaap/2025 | Promissory note - related party | 0 |
| 0001213900-25-052614 | 2 | 19 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-052614 | 2 | 20 | BS | 0 | H | Deferred Legal Fees | 0001213900-25-052614 | Deferred legal fees | 0 |
| 0001213900-25-052614 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2025 | TOTAL LIABILITIES | 0 |
| 0001213900-25-052614 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | COMMITMENTS AND CONTINGENCIES (Note 6) | 0 |
| 0001213900-25-052614 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | 0 |
| 0001213900-25-052614 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Ordinary shares, value | 0 |
| 0001213900-25-052614 | 2 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-052614 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-052614 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | TOTAL SHAREHOLDERS DEFICIT | 0 |
| 0001213900-25-052614 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | TOTAL LIABILITIES AND SHAREHOLDERS DEFICIT | 0 |
| 0001213900-25-052614 | 3 | 7 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preference shares, par value (in Dollars per share) | 0 |
| 0001213900-25-052614 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preference shares, shares authorized | 0 |
| 0001213900-25-052614 | 3 | 9 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preference shares, issued | 0 |
| 0001213900-25-052614 | 3 | 10 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preference shares, outstanding | 0 |
| 0001213900-25-052614 | 3 | 11 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Ordinary shares, par value (in Dollars per share) | 0 |
| 0001213900-25-052614 | 3 | 12 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Ordinary shares, shares authorized | 0 |
| 0001213900-25-052614 | 3 | 13 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Ordinary shares, issued | 0 |
| 0001213900-25-052614 | 3 | 14 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Ordinary shares, outstanding | 0 |
| 0001213900-25-052614 | 4 | 6 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative costs | 0 |
| 0001213900-25-052614 | 4 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001213900-25-052614 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-052614 | 4 | 9 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average shares outstanding, Class B ordinary shares(1)(2) (in Shares) | 0 |
| 0001213900-25-052614 | 4 | 10 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic net loss per share (in Dollars per share) | 0 |
| 0001213900-25-052614 | 4 | 11 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted net loss per share (in Dollars per share) | 0 |
| 0001213900-25-052614 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-052614 | 5 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-052614 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of ordinary shares | 0 |
| 0001213900-25-052614 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuance of ordinary shares (in Shares) | 0 |
| 0001213900-25-052614 | 5 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-052614 | 5 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-052614 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-052614 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-052614 | 6 | 4 | CF | 0 | H | Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-052614 | Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 0 |
| 0001213900-25-052614 | 6 | 5 | CF | 0 | H | Formation Costs Paid Via Advance From Related Party | 0001213900-25-052614 | Formation costs paid via advance from related party | 0 |
| 0001213900-25-052614 | 6 | 6 | CF | 0 | H | Operating Costs Paid Via Promissory Note Related Party | 0001213900-25-052614 | Operating costs paid via promissory note related party | 0 |
| 0001213900-25-052614 | 6 | 8 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 1 |
| 0001213900-25-052614 | 6 | 9 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-052614 | 6 | 10 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001213900-25-052614 | 6 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net Change in Cash | 0 |
| 0001213900-25-052614 | 6 | 12 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash Beginning of period | 0 |
| 0001213900-25-052614 | 6 | 13 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash End of period | 0 |
| 0001213900-25-052614 | 6 | 15 | CF | 0 | H | Deferred Offering Costs Included In Accrued Offering Costs | 0001213900-25-052614 | Deferred offering costs included in accrued offering costs | 0 |
| 0001213900-25-052614 | 6 | 16 | CF | 0 | H | Deferred Offering Costs Included In Deferred Legal Fees | 0001213900-25-052614 | Deferred offering costs included in deferred legal fees | 0 |
| 0001213900-25-052614 | 6 | 17 | CF | 0 | H | Deferred Offering Costs Paid Through Promissory Note Related Party | 0001213900-25-052614 | Deferred offering costs paid through promissory note - related party | 0 |
| 0001213900-25-052614 | 6 | 18 | CF | 0 | H | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-052614 | Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 0 |
| 0001213900-25-052614 | 6 | 19 | CF | 0 | H | Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-052614 | Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |